| P50 | author | ??? | Q38591102 |
| P2093 | author name string | Luft FC | |
| P2860 | cites work | Does superoxide underlie the pathogenesis of hypertension? | Q24560022 |
| | AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation | Q28139447 |
| | Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress | Q28372941 |
| | Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases | Q29547555 |
| | Cellular survival: a play in three Akts | Q29547806 |
| | Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 |
| | New insights into the interaction of Ras with the plasma membrane | Q33691054 |
| | State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action | Q33752650 |
| | Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | Q33903180 |
| | A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element | Q33923274 |
| | Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. | Q33991556 |
| | Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants | Q34033893 |
| | Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline | Q37351830 |
| | Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator | Q38359909 |
| | Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective | Q40584311 |
| | Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy | Q40870045 |
| | Endotoxin-induced renal inflammatory response. Oncostatin M as a major mediator of suppressed renin expression | Q40880558 |
| | Activate NF-kappa B or die? | Q41397219 |
| | Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells | Q42493329 |
| | ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis | Q42796771 |
| | Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. | Q47909651 |
| | High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. | Q50924399 |
| | High human renin hypertension in transgenic rats. | Q53003369 |
| | Blood pressure-independent effects in rats with human renin and angiotensinogen genes. | Q54062419 |
| | The hemoregulatory peptide N-acetyl-ser-asp-lys-pro impairs angiotensin I-induced contractions in rat aorta | Q60621588 |
| | NADH/NADPH Oxidase and Vascular Function | Q63365800 |
| | Transcription factors modulating angiotensinogen gene expression in hepatocytes | Q72118285 |
| | Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells | Q73087569 |
| | Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells | Q73176746 |
| | Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis | Q73182905 |
| | Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men | Q73205391 |
| | Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis | Q73267274 |
| | Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation | Q73340504 |
| | NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats | Q73371618 |
| | Angiotensin-converting enzyme expression in human carotid artery atherosclerosis | Q73371662 |
| | Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes | Q73371663 |
| | Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability | Q73590707 |
| | Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species | Q73675626 |
| | Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction | Q73783872 |
| | Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells | Q73873417 |
| | Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms | Q73919597 |
| | Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats | Q74172837 |
| | Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage | Q74188173 |
| | Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway | Q74316935 |
| | CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension | Q74316940 |
| | Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors | Q77215422 |
| | Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro | Q77330812 |
| | Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases | Q77804609 |
| | Hypertension-induced end-organ damage : A new transgenic approach to an old problem | Q77945584 |
| | Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension | Q77945688 |
| | Angiotensin induces inflammatory activation of human vascular smooth muscle cells | Q77974630 |
| | Angiotensin II (ATII)-inducible platelet-derived growth factor A-chain gene expression is p42/44 extracellular signal-regulated kinase-1/2 and Egr-1-dependent and mediated via the ATII type 1 but not type 2 receptor. Induction by ATII antagonized by | Q78122180 |
| P433 | issue | 1 | |
| P921 | main subject | arterial hypertension | Q41861 |
| | cardiovascular disease | Q389735 |
| | inflammation | Q101991 |
| P304 | page(s) | 61-67 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Angiotensin, inflammation, hypertension, and cardiovascular disease | |
| P478 | volume | 3 | |